Micromedic Technologies of Tel-Aviv at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine
Manufacturers

Micromedic Technologies

Kiryat Atidim, Bld. 7, 6158101 Tel-Aviv
Israel
Telephone +972 732753450
Fax +972 732753451
info@m-medic.com

Hall map

MEDICA 2018 hall map (Hall 18): stand F13

Fairground map

MEDICA 2018 fairground map: Hall 18

Our range of products

Product categories

  • 03  Diagnostics
  • 03.03  Haematology / histology / cytology testing
  • 03.03.02  Histology reagents, cytology reagents

Histology reagents, cytology reagents

Our products

Product category: Histology reagents, cytology reagents

CellDetect® Bladder Cancer

CellDetect® Bladder is an innovative urinary marker for the early detection of bladder cancer in urine specimens. Combining color and morphology, CellDetect® is particularly useful for the detection of low-grade tumors. It was also shown to have higher sensitivity than other current diagnostic methods for all bladder cancer grades, making it an effective early indicator of recurrence.

More Less

About us

Company details

Micromedic: Leading the Path to Introducing Novel Cancer Diagnostic Tools

Micromedic Technologies Ltd. is a public company traded on the Tel Aviv Stock Exchange (MCTC), focusing on the development and commercialization of cancer diagnostic products.

Micromedic focuses on the development and commercialization of innovative in vitro diagnostic solutions for early cancer detection. Particularly, CellDetect® is a new-generation cytopathological staining platform for the improved diagnosis of early-stage bladder cancer tumors. As opposed to standard histochemical stains which only rely on morphology, CellDetect® uses both color and morphology in order to differentiate between normal and malignant cells in urine specimens. This color feature dramatically enhances the diagnostic accuracy across all cancer stages, affording high sensitivity for low-grade tumors. Using equipment and processes available in all pathology laboratories, CellDetect® is also applicable to other types of cancers.

More Less